This stems largely from our incomplete knowledge of the true pathophysiology of AD in which abnormalities of Aβ peptide and tau processing, inflammation, oxidative stress, and vascular risk factors, amongst others, are postulated to contribute [70]. This evidence concerns the gene MAPT and Alzheimer disease.